Medically Home Acquisition, Valuation, Funding & Investors
Medically Home was acquired by DispatchHealth in March 2025.
Cumulative funding Medically Home raised
$274M
across 5 funding rounds
Key investors in Medically Home
Mayo Clinic
Cardinal Health
Kaiser Permanente
Wormhole Capital
Baxter International
Global Medical Response
About Medically Home
Medically Home is a Boston-headquartered provider of hospital-at-home services that equips health systems to deliver acute care directly in patients' residences. Its technology platform facilitates remote patient monitoring, clinician coordination, and access to a centralized command center for high-acuity conditions such as heart failure and COPD exacerbations. Launched in 2016, the company partners with leading institutions including Mayo Clinic, Cleveland Clinic, and UPMC to administer thousands of home-based hospital episodes across states like Tennessee, Texas, and Minnesota. Medically Home integrates telehealth, mobile diagnostic units, and pharmacy fulfillment to replicate inpatient capabilities outside traditional facilities, supporting Medicare-covered programs nationwide.
Founded
2016
HQ
Boston, MAWebsite
Status
Acquired
Customer focus
B2B
Revenue model
Services
Valuation
$3.5B (Jan 2022)
Medically Home Acquisition
Medically Home was acquired by DispatchHealth for an undisclosed price on 18 March 2025.
Before the acquisition Medically Home had raised $274M across 5 funding rounds.
Medically Home provides a hospital-at-home technology enablement model for health systems and physician groups to deliver emergency and hospital-level care at home, including for oncology and organ transplant patients via telehealth, virtual call centers, and in-home devices. DispatchHealth offers high-acuity in-home medical care for serious health concerns, including emergency-level care to avoid ED visits, hospital-alternative inpatient care at home, and transitional care for high readmission-risk patients post-hospital, ER, or skilled nursing stays, supported by mobile imaging and CLIA-certified mobile labs. On March 18, 2025, the companies announced a definitive merger agreement to create the nation's most comprehensive platform for complex care at home, operating across 50 major metropolitan areas in partnership with nearly 40 health systems, most major health plans, and value-based care entities; the deal closed in late May 2025, with Medically Home integrating under the DispatchHealth brand, which will phase out the Medically Home name while preserving existing customer agreements and services. The strategic rationale combines DispatchHealth's clinical care, logistics, and scale with Medically Home's technology platform and clinical command center model to expand to over 20 states, serve more than 50 enterprise customers, reduce total care costs by up to 30% over 30 days, free up over 62,000 hospital bed days annually, and address rising healthcare costs, hospital capacity strains, and patient preference for home-based care amid a hospital-at-home market projected to reach $300 billion by 2028. Transaction terms were not disclosed; DispatchHealth secured additional investment from existing investors of both companies to fund integration and growth. Advisors included MTS Health Partners and Polsinelli for DispatchHealth, Wilson Sonsini Goodrich & Rosati for DispatchHealth, and Cooley for Medically Home.
| Acquirer | Date | Type |
|---|---|---|
| 18 Mar 2025 | Strategic M&A |
Medically Home Valuation
Medically Home is currently valued at $3.5B, based on its undisclosed-stage round in January 2022.
The $110M round was led by Baxter International, Cardinal Health and Global Medical Response, with participation from Wormhole Capital, Kaiser Permanente and Mayo Clinic.
Medically Home valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Jan 2022 | Undisclosed stage | $3.5B |
Medically Home Funding History
Medically Home has raised a total of $274M across 5 funding rounds.
Medically Home's first fundraising round was a $14M Series A in June 2017. The most recent completed round was a $110M undisclosed-stage round in January 2022.
Medically Home funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jan 2022 | Undisclosed stage | Baxter International (lead); Cardinal Health (lead); Global Medical Response (lead); Wormhole Capital; Kaiser Permanente; Mayo Clinic | $110M | $3.5B | Medically Home provides a platform enabling health systems to deliver hospital-level acute care at patients' homes, combining centralized medical command centers with field clinicians like nurses, paramedics, and technicians, supported by national partners for medications, equipment, and technology. The model addresses hospital capacity pressures, patient preferences for home care, and clinician shortages by creating a decentralized care ecosystem. Over 7,000 patients had been treated via the platform by early 2022, with rapid expansion driven by partnerships with systems like Mayo Clinic and Kaiser Permanente. On January 10, 2022, Medically Home raised $110 million in a strategic investment round led by Baxter International, Global Medical Response (GMR), and Cardinal Health, each gaining board seats. Existing investors Cardinal Health, Mayo Clinic, and Kaiser Permanente added capital atop prior commitments, bringing total funding to between $275 million and $660 million across rounds. The investment strengthens logistics, clinical workforce scalability via GMR's 30,000 clinicians across 50 states, and innovation in digital health monitoring, accelerating national rollout amid post-COVID demand for home-based high-acuity care. Strategic partners highlighted synergies: Baxter advances hospital-at-home solutions for critical diseases; GMR leverages mobile healthcare expertise with proven at-home collaborations; Mayo Clinic emphasizes digital-era mission alignment. The round, announced at JPM 2022, positions Medically Home as a leader in hospital care at home, validating an ecosystem approach with health systems, distributors, and mobile providers. |
| May 2021 | Strategic investment | Kaiser Permanente; Mayo Clinic | $100M | - | Medically Home is a Boston-based company providing a technology and services platform that enables health systems to deliver hospital-level, high-acuity care in patients' homes, including treatments for cancer, heart failure, pneumonia, transfusions, and acute COVID-19. The model coordinates in-home clinician visits, technology, equipment, medications, and supplies, targeting 30% of U.S. hospitalized patients or over 10 million annually. Partners include Mayo Clinic, Kaiser Permanente, Adventist Health, ProMedica, UNC Health, Massachusetts General Hospital Cancer Center, Huron, and Cardinal Health. On May 13, 2021, Mayo Clinic and Kaiser Permanente announced a strategic joint investment of approximately $100 million in Medically Home to scale operations nationwide and support provider-led transformation in healthcare delivery. This funding builds on prior collaborations: Kaiser implemented the model in Northwest and Northern California in 2020 with plans to expand, while Mayo deployed it in Jacksonville, Florida, and Eau Claire, Wisconsin, treating over 300 patients with reduced readmissions, low complications, high satisfaction, and no unexpected morbidity or mortality. The investment also aims to share best practices across organizations and extend care to address social needs alongside medical ones. Medically Home had raised more than $64 million since launching in 2016, achieving double-digit growth in 2019, and grew to about 170 employees by 2021. The company positions itself for serious and complex care, enhancing perceptions in the market and regulatory environments through high-profile partnerships. |
| Nov 2020 | Series C | - | $40M | - | Medically Home is a Boston-based medtech company providing a platform for hospital-at-home care, enabling high-acuity treatments like COVID-19, heart failure, and cancer in patients' homes to increase health system capacity and meet patient preferences for home-based care. The company has raised over $258M across multiple rounds, with the latest being a $110M Series D in January 2022 led by Baxter International, Global Medical Response, and Cardinal Health, joined by Mayo Clinic and Kaiser Permanente. By early 2022, Medically Home had treated over 7,000 patients through deployments with health systems like Mayo Clinic and Kaiser Permanente, with rapid expansion amid pandemic-driven demand for decentralized care. Strategic investors gained board seats to support scaling nationwide, focusing on digital health innovations and partnerships in medtech and logistics. |
| May 2019 | Series B | Cardinal Health (lead) | $10M | - | Medically Home is a Boston-based technology-enabled services company that delivers hospital-level care directly to patients' homes using a virtual hospital platform, sending clinicians, technology, equipment, medication, and supplies to acutely ill patients' bedsides. The model transforms patient homes into temporary hospital units, enabling cost-effective, patient-centric care that costs roughly 30% less than traditional hospital stays. Founded in 2017, the company had successfully treated patients for two years prior to the round and aimed to scale its efforts nationwide. In May 2019, Medically Home raised $10 million in a Series B funding round led by Cardinal Health, with participation from other investors, bringing total capital raised between Series A and B to $24 million. The funding supported scaling the virtual hospital model, including expansion in Boston and announcement of joint venture partnerships. This strategic investment highlighted market momentum toward innovative value-based care models and alternative care delivery sites to reduce infrastructure costs. The round positioned Medically Home to meet growing demand for high-quality, cost-effective solutions amid provider capacity challenges and shifts toward virtual capacity substituting traditional inpatient settings. |
| Jun 2017 | Series A | - | $14M | - | - |
Who has invested in Medically Home?
6 investors have backed Medically Home across its funding rounds, including Mayo Clinic, Cardinal Health, Kaiser Permanente, Wormhole Capital, Baxter International and Global Medical Response.
Lead investors include Baxter International, Cardinal Health and Global Medical Response.
Medically Home Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| United States | 2 | Lead | May 2019 | |
| San Francisco, CA | 2 | Participant | May 2021 | |
| Rochester, MN | 2 | Participant | May 2021 | |
| New York City, NY | 1 | Participant | Jan 2022 | |
This data is available for Pro users. Sign up to see all 6 Medically Home investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialMedically Home Competitors
Medically Home competitors include listed companies like Hims and Ping An Healthcare, and private ones like Noom, Sword Health, Grow Therapy and Apollo Healthco.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| New York City, NY | Private | $400M | - | $3.7B | 9.3x | |
| New York City, NY | Private | $240M | - | $4B | 16.7x | |
| New York City, NY | Private | $1B | - | $3B | - | |
 India | Private | - | $18M | $2.7B | - | |
| United States | Publicly listed | $2.3B | $178M | $6.5B | 2.4x | |
 China | Publicly listed | $815M | $52M | $1.6B | 0.9x |
Medically Home Public Comps
Medically Home is no longer listed, but its public comps include Ping An Healthcare, JMDC, GoodRx, Teladoc, Talkspace, Hims, Guiyang Longmaster, Medley Inc., American Well and Oscar Health.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $815M | $52M | 0.9x | 0.9x | 13.4x | 16.9x | |||
| $324M | $88M | 5.0x | 4.6x | 18.4x | 17.9x | |||
| $797M | $173M | 1.8x | 1.8x | 8.1x | 5.5x | |||
| $2.5B | $124M | 0.6x | 0.6x | 11.3x | 5.0x | |||
| $229M | $6M | 3.4x | 3.4x | 129.3x | 49.4x | |||
| $2.3B | $178M | 3.1x | 2.4x | 40.4x | 23.9x | |||
| $44M | $5M | 10.0x | - | 87.9x | - | |||
| $236M | $32M | 2.1x | 1.8x | 15.7x | 13.2x | |||
This data is available for Pro users. Sign up to see all Medically Home competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Medically Home
| When was Medically Home founded? | Medically Home was founded in 2016. |
| Where is Medically Home headquartered? | Medically Home is headquartered in Boston, MA, United States. |
| Is Medically Home publicly listed? | No, Medically Home was acquired by DispatchHealth in March 2025. |
| Who acquired Medically Home? | Medically Home was acquired by DispatchHealth in March 2025. |
| What is Medically Home's valuation? | Medically Home was last valued at $3.5B in its undisclosed-stage round in January 2022. |
| How much funding has Medically Home raised? | Medically Home has raised $274M across 5 funding rounds. |
| What was Medically Home's last funding round? | Medically Home's last funding round was a $110M undisclosed-stage round in January 2022, led by Baxter International, Cardinal Health and Global Medical Response. |
| Who are Medically Home's investors? | Medically Home's investors include Cardinal Health, Kaiser Permanente, Mayo Clinic, Wormhole Capital, Baxter International and Global Medical Response. |
| Which companies are comparable to Medically Home? | Companies comparable to Medically Home include Noom, Sword Health, Grow Therapy, Apollo Healthco, Hims and Ping An Healthcare. |
See companies similar to Medically Home
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.